Keyphrases
Glanzmann Thrombasthenia
100%
Factor XI Deficiency
80%
Platelets
53%
Israel
49%
Ashkenazi Jews
37%
Integrin
34%
Polymorphism
27%
Jewish
26%
Fibrinogen
26%
Causal Factors
26%
Bleeding
26%
Thrombosis
25%
Jews
25%
Novel mutation
23%
Dubin-Johnson Syndrome
22%
Factor VIII Deficiency
22%
Autosomal Recessive
20%
Von Willebrand Factor
20%
Glycoprotein IIb
20%
Disulfide Bond
19%
Homozygote
19%
GPIIIa
18%
Iraqi Jews
18%
Hemophilia
16%
Prenatal Diagnosis
16%
Arab
16%
Jewish Population
16%
Recombinant Activated Factor VII (rFVIIa)
16%
Israeli
16%
Von Willebrand Disease
16%
Thrombin Generation
16%
Baby Hamster Kidney Cells
16%
Haplotype Analysis
15%
Jewish Patients
15%
Missense mutation
15%
Risk Factors
15%
Factor V Deficiency
14%
Surface Expression
14%
Factor VII Deficiency
14%
Acute Myocardial Infarction
14%
GPIIbIIIa
13%
Confidence Interval
13%
Tissue Factor
13%
Heterozygote
13%
Platelet Aggregation
13%
Glycoprotein IIIa
13%
Factor 9
13%
Methylenetetrahydrofolate Reductase (MTHFR)
12%
Factor V Leiden
12%
Proband
12%
Biochemistry, Genetics and Molecular Biology
Glanzmann's Thrombasthenia
85%
Factor XI
72%
Platelet
48%
Factor V
38%
Factor VIII
32%
Exon
31%
Fibrinogen
30%
Integrin
30%
Glycoprotein
29%
Haplotype
24%
Protein C
23%
Prevalence
22%
Factor VII
20%
Allele
18%
Surface Property
17%
Homozygote
17%
Genetics
16%
Autosomal Recessive Inheritance
15%
Gene Frequency
15%
Founder Effect
15%
Methylenetetrahydrofolate Reductase
14%
Homozygosity
12%
Thrombophilia
11%
Disulfide Bond
11%
Eicosanoid Receptor
11%
Amino Acids
11%
Haemophilia A
11%
Binding Site
10%
Missense Mutation
10%
Platelet Glycoprotein
10%
Von Willebrand Factor
10%
Thrombocyte Aggregation
9%
Factor V Leiden
9%
Vitronectin
9%
Protein S
9%
Prothrombin
9%
BRCA1
9%
Wild Type
8%
Restriction Map
8%
Proband
8%
Factor XIII
8%
Heterozygote
8%
Genetic Carrier
8%
Von Willebrand Disease
8%
Coagulation Factor V
8%
Messenger RNA
8%
LMAN1
8%
Factor XIII Deficiency
8%
Intron
8%
Normal Human
7%
Medicine and Dentistry
Factor XI
43%
Glanzmann's Thrombasthenia
39%
Bleeding
31%
Disease
19%
Factor V
18%
Platelet
18%
Dubin-Johnson Syndrome
16%
Blood Clotting Factor 8
15%
Thrombosis
15%
Prothrombin
13%
Integrin
13%
Factor VII
12%
Haemophilia A
11%
Protein C
10%
Bleeding Disorder
10%
Von Willebrand Factor
10%
Injury
10%
Thrombophilia
10%
Fibrinogen
9%
Phlebothrombosis
9%
Protein C Deficiency
9%
Bleeding Diathesis
8%
Recombinant Blood Clotting Factor 7a
8%
Multidrug Resistance Associated Protein 2
8%
Substitution Therapy
8%
Prevalence
8%
Von Willebrand Disease
7%
Pre-Eclampsia
7%
Autosomal Recessive Inheritance
7%
Factor V Leiden
7%
Thrombin
7%
Computer Assisted Tomography
7%
Disulfide
7%
Disseminated Intravascular Coagulation
7%
Venous Thromboembolism
6%
Haplotype
6%
Purpura fulminans
6%
Heparin
6%
Platelet Disorder
6%
Symptom
6%
Thrombocyte Aggregation
6%
Vitronectin Receptor
6%
Acute Heart Infarction
5%
Blood Stasis
5%
Homozygote
5%
Systemic Lupus Erythematosus
5%
Multiple Myeloma
5%
Pregnancy Complication
5%
Blood Clotting Factor 8 Inhibitor
5%
Stenosis
5%
